Figure 3.

Reactive therapeutic drug monitoring-based algorithm for optimizing infliximab therapy in inflammatory bowel disease.
ATI: antibodies to infliximab; TDM: therapeutic drug monitoring.

Reactive therapeutic drug monitoring-based algorithm for optimizing infliximab therapy in inflammatory bowel disease.
ATI: antibodies to infliximab; TDM: therapeutic drug monitoring.